Home       About             Help      

Select plot or tool >
Pheno measurements correlated to your selected measurements

Pearson correlation p value
must be p ≤


Download all
At least
strains
in common
are required
Include:
females and males
females only
males only

Order by


More info on correlations


Your selected measurement:
brain — cerebral cortex — biochemical analytes         reverse ELISA  
Wiltshire3
SLC6A4_index   sodium-dependent serotonin transporter (SLC6A4 formerly SERT), change index   fluoxetine  
30 strains   age 10-11wks
  Inbred
 

Download this list as a tab-delimited file
 
Correlated measurement from anywhere in MPD
(organized by category)
Sex Pearson
r
p value
on r
Spearman
rs
# strains
in
common
Click
for
scatterplot
Log-
improved
Pearson
behavior – anxiety
Brown1   urination_EZM  
urine puddle count
male –0.83 p = 0.0062 –0.54 9 Plot  
behavior – stress reactivity
Wiltshire2   TST_fluox  
percent time spent immobile in tail suspension test (fluoxetine )
male –0.56 p = 0.0014 –0.40 30 Plot  
blood – hematology – cell counts – WBC – monocytes
Petkova1   MONO_M12  
monocytes (percent of viable WBC) (age 12mo)
male –0.56 p = 0.0089 –0.39 21 Plot  
blood – hematology – cell counts – WBC – neutrophils
Peters4   NEUT_M06  
neutrophil count (NEUT; units per volume x 103) (age 6mo)
male –0.72 p = 0.0003 –0.25 20 Plot  
blood – hematology – platelets
Peters4   MPV_M12  
mean platelet volume (MPV) (age 12mo)
male –0.57 p = 0.0093 –0.53 20 Plot  
blood – lipids – cholesterol – HDL
Paigen1   pctHDL-TCH  
percent of total plasma cholesterol in HDL fraction (high-fat diet 8wks)
male –0.59 p = 0.0021 –0.59 25 Plot  
Paigen2   HDLC_fat17  
HDL cholesterol (high-fat diet 17wks)
male –0.55 p = 0.0091 –0.53 21 Plot -0.58
body composition – fat
Naggert1   fatwt_fat8  
weight of fat portion of tissue mass, head excluded (high-fat diet 8wks)
male –0.54 p = 0.0074 –0.48 23 Plot  
Naggert1   pctfat_fat8  
percent of tissue mass that is fat, head excluded (high-fat diet 8wks)
male –0.53 p = 0.0094 –0.46 23 Plot  
body weight size and growth – body weight
Paigen1   finalbw  
final body weight (high-fat diet 8wks)
male –0.54 p = 0.0056 –0.52 25 Plot  
body weight size and growth – body weight growth curve
Jax1   bw4  
body weight
male –0.88 p = 0.0018 –0.83 9 Plot  
Jax1   bw5  
body weight
male –0.80 p = 0.0097 –0.77 9 Plot  
bone – mineral density and content
Naggert1   BMD_fat8  
bone mineral density (BMD) (high-fat diet 8wks)
male –0.67 p = 0.0005 –0.71 23 Plot  
Ackert1   BMD_M20  
whole body bone mineral density (BMD, Head excluded) (age 20mo)
male –0.74 p = 0.0007 –0.72 17 Plot  
Tordoff3   BMD  
bone mineral density (BMD)
male –0.63 p = 0.0007 –0.65 25 Plot  
Donahue1   spine_BMD  
spine (L2-L5) bone mineral density
male –0.65 p = 0.0035 –0.67 18 Plot  
Naggert1   BMC_fat8  
bone mineral content (BMC) (high-fat diet 8wks)
male –0.54 p = 0.0073 –0.63 23 Plot  
HMDPpheno1   BMD_spine  
bone mineral density (BMD) of lumbar spine
male –0.55 p = 0.0081 –0.55 22 Plot  
HMDPpheno1   BMD_spine_inb  
bone mineral density (BMD) of lumbar spine, inbred strains only
male –0.55 p = 0.0081 –0.55 22 Plot  
bone – strength
Donahue2   elastic_modulus  
estimated elastic modulus
male –0.81 p = 0.0089 –0.73 9 Plot  
Donahue2   ultimate_strength  
estimated ultimate strength
male –0.80 p = 0.0096 –0.62 9 Plot  
brain – cerebral cortex
Wiltshire3   SLC6A4_fluox  
sodium-dependent serotonin transporter (SLC6A4 formerly SERT), relative fluorescence intensity (fluoxetine )
male 0.89 p < 0.0001 0.73 30 Plot  
Wiltshire3   NPY_index  
neuropeptide Y (NPY), change index (fluoxetine )
male 0.84 p < 0.0001 0.73 30 Plot  
Wiltshire3   TNF_index  
tumor necrosis factor (TNF formerly TNFa), change index (fluoxetine )
male 0.82 p < 0.0001 0.59 30 Plot  
Wiltshire3   GRIN1_index  
glutamate receptor NMDA1 subunit zeta 1 (GRIN1 formerly NMDA1), change index (fluoxetine )
male 0.80 p < 0.0001 0.66 30 Plot  
Wiltshire3   SCG5_index  
secretogranin V (SCG5 formerly SGNE), change index (fluoxetine )
male 0.79 p < 0.0001 0.76 30 Plot  
Wiltshire3   SLC6A2_index  
sodium-dependent noradrenaline transporter (SLC6A2 formerly NET), change index (fluoxetine )
male 0.78 p < 0.0001 0.64 30 Plot  
Wiltshire3   SCG5_fluox  
secretogranin V (SCG5 formerly SGNE), relative fluorescence intensity (fluoxetine )
male 0.77 p < 0.0001 0.59 30 Plot  
Wiltshire3   APOD_index  
apolipoprotein D (APOD), change index (fluoxetine )
male 0.75 p < 0.0001 0.28 30 Plot  
Wiltshire3   NPY_fluox  
neuropeptide Y (NPY), relative fluorescence intensity (fluoxetine )
male 0.74 p < 0.0001 0.51 30 Plot  
Wiltshire3   CREB1_index  
cyclic AMP-responsive element-binding protein 1 (CREB1 formerly CREB), change index (fluoxetine )
male 0.74 p < 0.0001 0.53 30 Plot  
Wiltshire3   FUT9_index  
fucosyltransferase 9 (FUT9), change index (fluoxetine )
male 0.73 p < 0.0001 0.54 30 Plot  
Wiltshire3   GHRL_index  
ghrelin (GHRL), change index (fluoxetine )
male 0.70 p < 0.0001 0.50 30 Plot  
Wiltshire3   SLC6A4_cont  
sodium-dependent serotonin transporter (SLC6A4 formerly SERT), relative fluorescence intensity
male –0.70 p < 0.0001 –0.77 30 Plot  
Wiltshire3   BDNF_index  
brain-derived neurotrophic factor (BDNF), change index (fluoxetine )
male 0.69 p < 0.0001 0.38 30 Plot  
Wiltshire3   GSR_index  
glutathione reductase (GSR), change index (fluoxetine )
male 0.69 p < 0.0001 0.44 30 Plot  
Wiltshire3   ACTH_index  
adrenocorticotropic hormone (ACTH), change index (fluoxetine )
male 0.68 p < 0.0001 0.30 30 Plot  
Wiltshire3   FOS_index  
proto-oncogene c-Fos (FOS formerly c-fos), change index (fluoxetine )
male 0.68 p < 0.0001 0.38 30 Plot  
Wiltshire3   GAD1_fluox  
glutamate decarboxylase 1 (GAD1 formerly GAD67), relative fluorescence intensity (fluoxetine )
male 0.67 p < 0.0001 0.55 30 Plot  
Wiltshire3   GAD1_index  
glutamate decarboxylase 1 (GAD1 formerly GAD67), change index (fluoxetine )
male 0.67 p < 0.0001 0.61 30 Plot  
Wiltshire3   S100B_index  
protein S100-B (S100B), change index (fluoxetine )
male 0.67 p < 0.0001 0.63 30 Plot  
Wiltshire3   GIRK3_index  
G protein-activated inward rectifier potassium channel 3 (GIRK3 formerly KCNJ9), change index (fluoxetine )
male 0.64 p = 0.0001 0.31 30 Plot  
Wiltshire3   PAQR8_index  
progestin and adipoQ receptor family member VIII (PAQR8), change index (fluoxetine )
male 0.64 p = 0.0001 0.45 30 Plot  
Wiltshire3   CREB1_fluox  
cyclic AMP-responsive element-binding protein 1 (CREB1 formerly CREB), relative fluorescence intensity (fluoxetine )
male 0.64 p = 0.0001 0.24 30 Plot  
Wiltshire3   GRIN1_fluox  
glutamate receptor NMDA1 subunit zeta 1 (GRIN1 formerly NMDA1), relative fluorescence intensity (fluoxetine )
male 0.63 p = 0.0002 0.47 30 Plot  
Wiltshire3   GFAP_index  
glial fibrillary acidic protein (GFAP), change index (fluoxetine )
male 0.62 p = 0.0003 0.50 30 Plot  
Wiltshire3   TNF_fluox  
tumor necrosis factor (TNF formerly TNFa) relative fluorescence intensity (fluoxetine )
male 0.60 p = 0.0005 0.20 30 Plot  
Wiltshire3   TNF_cont  
tumor necrosis factor (TNF formerly TNFa), relative fluorescence intensity
male –0.60 p = 0.0005 –0.63 30 Plot  
Wiltshire3   GRIN1_cont  
glutamate receptor NMDA1 subunit zeta 1 (GRIN1 formerly NMDA1), relative fluorescence intensity
male –0.59 p = 0.0005 –0.57 30 Plot  
Wiltshire3   S100B_fluox  
protein S100-B (S100B), relative fluorescence intensity (fluoxetine )
male 0.59 p = 0.0006 0.57 30 Plot  
Wiltshire3   SST_index  
somatostatin (SST), change index (fluoxetine )
male 0.58 p = 0.0008 0.41 30 Plot  
Wiltshire3   PAQR8_fluox  
progestin and adipoQ receptor family member VIII (PAQR8), relative fluorescence intensity (fluoxetine )
male 0.57 p = 0.0010 0.30 30 Plot  
Wiltshire3   GLO1_index  
glyoxalase 1 (GLO1), change index (fluoxetine )
male 0.57 p = 0.0011 0.13 30 Plot  
Wiltshire3   FUT9_cont  
fucosyltransferase 9 (FUT9), relative fluorescence intensity
male –0.56 p = 0.0012 –0.43 30 Plot  
Wiltshire3   VEGFA_index  
vascular endothelial growth factor A (VEGFA formerly VEGF), change index (fluoxetine )
male 0.56 p = 0.0013 0.20 30 Plot  
Wiltshire3   APOD_cont  
apolipoprotein D (APOD), relative fluorescence intensity
male –0.56 p = 0.0013 –0.62 30 Plot  
Wiltshire3   SLC6A2_fluox  
sodium-dependent noradrenaline transporter (SLC6A2 formerly NET), relative fluorescence intensity (fluoxetine )
male 0.56 p = 0.0014 0.26 30 Plot  
Wiltshire3   GLO1_cont  
glyoxalase 1 (GLO1), relative fluorescence intensity
male –0.55 p = 0.0017 –0.39 30 Plot  
Wiltshire3   BAG1_index  
BAG family molecular chaperone regulator 1 (BAG1), change index (fluoxetine )
male 0.54 p = 0.0020 0.15 30 Plot  
Wiltshire3   PTH_index  
parathyroid hormone (PTH), change index (fluoxetine )
male 0.54 p = 0.0021 0.19 30 Plot  
Wiltshire3   PPP1R1B_fluox  
protein phosphatase 1 regulatory (inhibitor) subunit 1B (PPP1R1B), relative fluorescence intensity (fluoxetine )
male 0.54 p = 0.0021 0.47 30 Plot  
Wiltshire3   BDNF_fluox  
brain-derived neurotrophic factor (BDNF), relative fluorescence intensity (fluoxetine )
male 0.54 p = 0.0023 0.25 30 Plot  
Wiltshire3   GHRL_cont  
ghrelin (GHRL), relative fluorescence intensity
male –0.53 p = 0.0028 –0.52 30 Plot  
Wiltshire3   GHRL_fluox  
ghrelin (GHRL), relative fluorescence intensity (fluoxetine )
male 0.52 p = 0.0029 0.29 30 Plot  
Wiltshire3   GIRK3_fluox  
G protein-activated inward rectifier potassium channel 3 (GIRK3 formerly KCNJ9), relative fluorescence intensity (fluoxetine )
male 0.50 p = 0.0047 0.05 30 Plot  
Wiltshire3   SLC6A2_cont  
sodium-dependent noradrenaline transporter (SLC6A2 formerly NET), relative fluorescence intensity
male –0.50 p = 0.0051 –0.59 30 Plot  
endocrine – hormones
Naggert1   LEP_fat18  
leptin (high-fat diet 18wks)
male –0.60 p = 0.0011 –0.51 26 Plot  
liver – protein homeostasis
Rusyn5   liver_SAM_hf  
liver S-adenosylmethionine (SAM) (high-fat diet 4wks)
male –0.84 p = 0.0083 –0.36 8 Plot  
metabolism – food intake
Evsikova1   food_Dk  
food intake, dark cycle (age 6mo)
male 0.79 p = 0.0070 0.73 10 Plot  
respiratory – breathing pattern
Berndt2   inspiratory_saline  
inspiratory time (Ti), saline
male –0.63 p = 0.0013 –0.69 23 Plot  
Berndt2   penh_slope  
enhanced pause (Penh), MCh response index (methacholine )
male 0.63 p = 0.0014 0.67 23 Plot  
Berndt2   breath_freq_saline  
breath frequency (F), saline
male 0.62 p = 0.0016 0.67 23 Plot 0.65
Berndt2   tot_respi_saline  
total respiratory time (Ttot), saline
male –0.62 p = 0.0018 –0.62 23 Plot  
Berndt2   insp_flow_saline  
inspiratory flow rate (Vt/Ti), saline
male 0.60 p = 0.0024 0.78 23 Plot  
Berndt2   inspiratory_mch5  
inspiratory time (Ti) (methacholine 5mg/mL)
male –0.60 p = 0.0026 –0.60 23 Plot  
Berndt2   min_vent_saline  
minute ventilation (MV), saline
male 0.59 p = 0.0028 0.75 23 Plot 0.62
Berndt2   inspiratory_slope  
inspiratory time (Ti), MCh response index (methacholine )
male 0.58 p = 0.0034 0.60 23 Plot  
Berndt2   expiratory_saline  
expiratory time (Te), saline
male –0.56 p = 0.0059 –0.57 23 Plot  
Berndt2   resp_flow_saline  
respiratory flow rate (Vt/Ttot), saline
male 0.55 p = 0.0066 0.74 23 Plot  
Berndt2   tot_respi_mch5  
total respiratory time (Ttot) (methacholine 5mg/mL)
male –0.54 p = 0.0075 –0.64 23 Plot  
Berndt2   breath_freq_mch5  
breath frequency (F) (methacholine 5mg/mL)
male 0.53 p = 0.0096 0.64 23 Plot 0.56
 

81 rows

Reciprocals are included in the above list.

Correlations where Pearson r < 0.5 are not retained and will not appear in the above list.

All correlations available through MPD are mathematical correlations provided for exploratory use, and are not necessarily biologically significant. Additional forms of validation are required. Most correlations are based on strain mean data points which have varying degrees of quality, preciseness, and normality of distribution, and this is generally not taken into account in correlation strength metrics.




Hosted by:
  Contact us
About MPD
Also at JAX
  Units
Changelog
Downloads
  Citing
Funding
Terms of Use